MGMT and neoplasm: In 75% of cases, tumor progression was encountered after STR or biopsy, including in three patients with postoperative radio- or chemotherapy; nonetheless, recurrence was also observed in four patients after GTR, with all but one harboring MGMT promoter methylation (Table S1).